Rohto Pharmaceutical Co.,Ltd.
4527
Rank in Stocks
#3845
Established in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global... Established in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global entity engaged in the development, manufacturing, and marketing of a diverse array of pharmaceutical goods, beauty products, and nutritional supplements. Their comprehensive product line includes various ophthalmic solutions such as eye drops, contact lens care products, and eye washes. For skincare, they offer facial treatments like cleansers, toners, and creams, in addition to specialized medicated preparations for the skin. The company's offerings also extend to internal medicines, encompassing digestive aids, herbal remedies, and dietary supplements. Furthermore, they supply over-the-counter medications and deliver beauty and health services via dedicated counters. The company rebranded from Yamada Pharmaceutical to Rohto Pharmaceutical Co.,Ltd. in September 1949.
Share Price
$19.03
Market Cap
$4.30B
Change (1 day)
0.15%
Change (1 year)
16.15%
Country
JP
Trade Rohto Pharmaceutical Co.,Ltd. (4527)
Category
Consumer Defensive
P/E ratio for Rohto Pharmaceutical Co.,Ltd. (4527)
P/E ratio as of October 2026 TTM: 19.80
According to Rohto Pharmaceutical Co.,Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 19.80. At the end of 2024 the company had a P/E ratio of 22.15.
P/E ratio history for Rohto Pharmaceutical Co.,Ltd. from 2008 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 19.80 | 20.52% |
| 2025 | 16.43 | -25.82% |
| 2024 | 22.15 | -7.53% |
| 2023 | 23.96 | 20.09% |
| 2022 | 19.95 | -0.84% |
| 2021 | 20.12 | -8.15% |
| 2020 | 21.91 | -34.07% |
| 2019 | 33.22 | -8.93% |
| 2018 | 36.48 | 53.81% |
| 2017 | 23.72 | -7.39% |
| 2016 | 25.61 | 14.05% |
| 2015 | 22.46 | -4.59% |
| 2014 | 23.54 | 32.38% |
| 2013 | 17.78 | 21.64% |
| 2012 | 14.62 | 13.70% |
| 2011 | 12.86 | -16.12% |
| 2010 | 15.33 | -9.35% |
| 2009 | 16.91 | -10.87% |
| 2008 | 18.97 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 23.20 | 17.14% |
US
|
|
| 32.48 | 64.04% |
FR
|
|
| 36.47 | 84.18% |
US
|
|
| 29.80 | 50.52% |
IN
|
|
| 199.20 | 906.00% |
US
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.